VSee Health entered a comprehensive settlement with ADI Funding and M2B Funding to resolve disputes tied to an ADI-secured note and ELOC-related obligations. The agreement sets a structured repayment plan, including repayment of the existing ADI note within 90 days or upon receipt of financing proceeds, application of 50% of new financing (100% from the ELOC) to the note, a $50,000 cash payment to ADI, and issuance of 1.0 million restricted shares. As part of the settlement, VSee issued two convertible notes totaling $175,000: $50,000 to ADI and $125,000 to M2B, each maturing in six months, with 0% interest pre-maturity and 18% if unpaid at maturity, and a 25% discount to the lowest 20-day VWAP on conversion. The package aims to resolve defaults and stabilize near-term liquidity.

Agreement 1: VSee Health Reaches Settlement With ADI and M2B, Setting Repayment Plan and Share Issuances

  • Agreement type: Settlement Agreement and Mutual Release with repayment and equity consideration
  • Counterparty: ADI Funding and M2B Funding
  • Signed / Effective: Jul 21 2026 / Jul 21 2026
  • Duration / Termination: Through full performance; repayment trigger at 90 days or upon financing
  • Reason: Resolve default and structure repayment obligations

Agreement 2: VSee Health Issues $50,000 Convertible Note to ADI as Part of Settlement

  • Agreement type: Six-month unsecured convertible promissory note ($50,000)
  • Counterparty: ADI Funding
  • Signed / Effective: Jul 21 2026 / Jul 21 2026
  • Duration / Termination: 6 months
  • Reason: Settlement consideration and repayment flexibility

Agreement 3: VSee Health Issues $125,000 Convertible Note to M2B as Part of Settlement

  • Agreement type: Six-month unsecured convertible promissory note ($125,000)
  • Counterparty: M2B Funding
  • Signed / Effective: Jul 21 2026 / Jul 21 2026
  • Duration / Termination: 6 months
  • Reason: Settlement consideration and liquidity support

Original SEC Filing:

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.